Ista Vitrase deal with Otsuka

ISTA granted Otsuka (Tokyo, Japan) exclusive Japanese development and marketing rights to its Vitrase to treat severe vitreous hemorrhage and diabetic retinopathy. Otsuka will be responsible for all d...